And Cencora pushes a takedown of ICER's approach to gene therapy
And a useful link on the most important part of the IRA that no one (but you all) has heard of
And I'd love to know whether you're headed to JPM24 and/or want to watch hockey
Plus thinking about the connection between jet fuel and obesity meds
So I can't even get to obesity or copay accumulators until tomorrow
Plus a must-read paper on what the IRA will do to formularies, and how that will impact patients
And the government is going to pay $85 or so for the new COVID-19 vaccines
And how tens of billions in 340B drug sales hinges on the definition of 'patient'
And a reminder: we could get some judicial action in an IRA case this week
Plus a brief detour to talk about how drugmakers disclose population size for new meds
And PhRMA has a new judge and AZ has a 'target date' for a decision in its case
Plus the early rumblings on how a shutdown with impact health policy
